ANI Pharmaceuticals (ANIP)

[silvr_surfr]

Well the Endo 2023 Scientific Statement is underwhelming. Here is the summary. It is always more research is needed. Hopefully, that is where the Libigel results will come in.

Key points from the statement:
Menopausal symptoms are common, vary in degree of discomfort and can be effectively treated with a variety of medications, yet these symptoms are still undertreated.

More research is needed to decide when older adults should receive testosterone-replacement therapy and to understand the adverse effects of

More data is needed to determine the optimal treatment goals in older people with diabetes.

Fractures are often not recognized as being related to osteoporosis, and as a result, most older patients with a fracture are not treated to prevent their next fracture.

Methods to distinguish between age-associated changes in thyroid function and early hypothyroidism are needed.

No therapy to increase growth hormone secretion or action is currently approved as an anti-aging intervention, and the risks may outweigh the benefits.
Some research has shown benefits of vitamin D supplementation in older adults, but standardized guidelines on appropriate vitamin D levels are lacking.